Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Job title: Associate Director, Clinical Marketing
Lynne Brown is an Associate Director of Clinical Marketing at Philips Healthcare, with responsibility for cardiovascular ultrasound products and advanced imaging technologies. Her work focuses on clinical strategy, education, and product adoption in cardiac imaging, drawing on more than 20 years of experience in echocardiography and clinical ultrasound practice.Professional ExperienceBrown joined… View more
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. Headquartered in St. Paul, Minn., St. Jude Medical… View more
Research Area(s) / Expertise:

Peripheral Artery Disease - General

Job title: Associate Professor of Vascular Surgery
Professor Varcoe is a vascular surgeon at Sydney’s Prince of Wales Hospitals where he is director of the operating theatres and of the Vascular Institute, one of Australia’s most prestigious clinical trials centres. His clinical practice specialises in the minimally invasive treatment of aortic conditions, carotid disease and the full gamut of occlusive arterial disease of the lower limb for… View more
Personal History Dr Robert Alexander Sykes is a PhD candidate and Research Fellow at the University of Glasgow. He is based in the West of Scotland for clinical and research training.4 Academic History He achieved both his BMedSci (2012 - 2013) and his MBChB (2010 - 2016) at the University Of Edinburgh. In 2018, he obtained a Postgraduate Certificate in Health Professionals Education… View more
Job title: Consultant Interventional Cardiologist
John Rawlins is a Consultant Interventional Cardiologist with a specialist interest in complex coronary and transcatheter valve intervention at University Hospital Southampton (UHS) NHS Trust, having been appointed in 2016. He currently leads the TAVI team at UHS.He qualified from Imperial College School of Medicine in 2003, having completed a BSc in Physiology at University College London in… View more
Job title: Head of Cardiology
Personal History Dr Lilia M. Sierra-Galan is based in Mexico City, Mexico, where she works as the head of cardiology at the Santa Fe Campus of the American British Cowdray Medical Center. Academic History Dr Lilia M. Sierra-Galan, MD earned her MD in Mexico and her cardiovascular imaging fellowship at the National Institute of Health in Bethesda, Washington DC and InCor in Sao Paulo,… View more
Job title: Professor of Clinical Medicine
Ajay J Kirtane, is Professor of Medicine at the Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian (NYP) Hospital / CUMC. Dr. Kirtane is an internationally-renowned leader in Interventional Cardiology, specializing in the care of patients with complex coronary and peripheral vascular disease. In addition to his… View more
Added: 4 months ago Source:  Radcliffe CVRM
The human metabolome reflects a complex interplay of genetic and environmental factors. A large-scale analysis integrating blood metabolomic, genomic, and lifestyle data from ten prospective cohorts has identified a comprehensive profile of circulating metabolites that are associated with the future risk of developing type 2 diabetes (T2D).¹MethodologyResearchers conducted a pooled analysis of 23… View more
Author(s): Fozia Ahmed , Smeeta Sinha Added: 3 months ago
This non-promotional meeting has been organised and funded by Novo Nordisk and is intended for UK healthcare professionals.Following an expert roundtable led by Prof Smeeta Sinha (Northern Care Alliance NHS Foundation Trust), Prof Ramzi Khamis (Imperial College London), Dr Daniel Bromage (King's College London), Dr Fozia Ahmed (NIHR Manchester BRC and CRF) and Prof Kelvin Lee (Lincolnshire Heart… View more
Added: 1 year ago Source:  Radcliffe CVRM
AUTHOR: Ola WisniewskaSodium-glucose cotransporter-2 (SGLT2) inhibitors significantly slow kidney function decline in patients with type 2 diabetes, with even greater benefits seen in those with higher body mass index (BMI), according to a nationwide Japanese study published recently.1Researchers analyzed data from 2,165 patients prescribed SGLT2 inhibitors compared with 4,330 matched patients on… View more